Originally published here.
Season 1 Episode 3: "Empowering Women's Health: A Conversation with Mary Kerr, CEO of NeRRe Therapeutics"
Keywords
women's health, menopause, women in science, fibroids, Endometriosis
Episode 3 of "The Biotech Pulse" features Geert-Jan Mulder, Managing Partner and one of the founders of Forbion, interviewing Mary Kerr, CEO of NeRRe Therapeutics. They discuss the challenges and opportunities in women's health, particularly in biotech. Mary shares insights into her career journey, emphasizing the need for more focus on women's health, addressing unmet needs in conditions like endometriosis and fibroids. They also touch on the recent success of KaNDy Therapeutics, a non-hormonal treatment for menopausal symptoms, and its acquisition by Bayer. The conversation highlights the evolving landscape and increasing interest in women's health within the biotech and venture capital sectors.
About The Biotech Pulse - a Forbion podcast
Forbion is a leading life sciences venture capital firm founded in the Netherlands, helping companies bridge research and development through our team's expertise in drug development and company building. For over 15 years, we have invested in over 100 companies backing exciting therapies that we believe have the potential to impact the future of medicine. The Biotech Pulse is a forum where we speak about all things biotech with diverse stakeholders in the life sciences industry.
